版本:
中国

BRIEF-Prothena Corp, Prothena Biosciences enter letter agreement with Boehringer Ingelheim

April 12 Prothena Corporation Plc

* Prothena Corporation - on April 5, 2017, co and Prothena Biosciences entered letter agreement with Boehringer Ingelheim Biopharmaceuticals GMBH

* Prothena Corp - Boehringer Ingelheim reserved for Prothena capacity to manufacture and supply bulk drug substance of NEOD001, PRX003, possibly additional biologics

* Prothena Corp - under agreement, Prothena made commitments for purchase of products from Boehringer Ingelheim Source text: (bit.ly/2psItli) Further company coverage:

我们的标准: 汤森路透“信任原则

更多 公司新闻(英文)

热门文章

编辑推荐

文章推荐